Hello Scott, have a look at the link FDApproved included in the post #8260. It contains information about 6 trials. At the top of the page you see ‘Trial record 1-6’, click through to ‘Trial record 3 of 6’. There you find relevant data relating to the IC trial. It is stated that the trial is ongoing but not recruiting. When you click on the ‘Full View’ option and then scroll down it tells you that there are 34 study locations involved in this trial. You can click on that for further details. The estimated completion date is April 2018. This corresponds with Pluristem’s latest Financial Statement.
‘In January 2017, we announced that we had completed enrollment of all 172 patients in the randomized, double blind, placebo controlled, multinational Phase II intermittent claudication (IC) clinical trial. We anticipate data readout in first half of 2018.’
News 
Market Data 
Discover 
